RadNet (RDNT) reports record Q4 2025 revenue of $547.7M, up 14.8%, with Digital Health surging 48% and strong 2026 guidance driven by AI growth. The post RadNetRadNet (RDNT) reports record Q4 2025 revenue of $547.7M, up 14.8%, with Digital Health surging 48% and strong 2026 guidance driven by AI growth. The post RadNet

RadNet (RDNT) Delivers Record-Breaking Q4 2025 Results as Digital Health Revenue Climbs 48%

2026/03/02 20:47
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Executive Summary

  • Fourth quarter revenue climbs 14.8% year-over-year, powered by imaging center expansion and operational optimization.
  • Digital Health platform experiences 48% revenue acceleration, bolstered by AI-powered subscription services.
  • Advanced imaging modalities including MRI, CT, and PET/CT demonstrate double-digit volume increases.
  • Full-year 2026 projections: Imaging revenue growth of 17–19%, EBITDA expansion of 18–22%, and free cash flow surge of 29–41%.
  • Strategic Gleamer acquisition enhances AI capabilities; multiple FDA submissions targeted for 2026.

RadNet, Inc. (RDNT) settled at $69.81 in regular trading, declining 3.16% (-$2.28), though pre-market activity indicates recovery momentum to $74.50, representing a 6.72% advance.

RadNet, Inc., RDNT
RadNet, Inc. achieved unprecedented quarterly revenue of $547.7 million during the fourth quarter of 2025, reflecting a 14.8% advancement from the prior year’s $477.1 million. The company reported adjusted EBITDA of $87.7 million, marking a 16.9% improvement year-over-year. Robust procedure volumes combined with enhanced operational execution drove performance throughout the Imaging Center business unit.

The Digital Health division generated $27.9 million in revenue, demonstrating exceptional 48.2% growth compared to $18.9 million in the comparable 2024 period. Adjusted EBITDA for this segment reached $4.9 million, climbing 8.9% from the previous year. The organization maintained a consolidated Adjusted EBITDA margin of 16%, expanding 29 basis points annually.

Adjusted earnings per share held steady at $0.23, versus $0.24 in the year-ago quarter, when excluding non-recurring items. The company recorded a net loss of $0.6 million on an unadjusted basis, contrasting with net income of $5.3 million in Q4 2024. Weighted average diluted share count increased modestly to 76.6 million from 75.5 million during the comparative period.

Imaging Operations Demonstrate Robust Volume Expansion

Aggregate advanced imaging procedure counts advanced 14.1%, while same-center procedures expanded 9.6% compared to Q4 2024. MRI examinations increased 15.8%, CT scans grew 10.3%, and PET/CT studies surged 28.3% on an aggregate basis. Same-center metrics showed 11.4% growth for MRI, 6.3% for CT, and 14.3% for PET/CT, demonstrating consistent operational execution.

Full-year 2025 Imaging Center revenue played a pivotal role in achieving the company’s $2.04 billion annual top line. Annual adjusted EBITDA totaled $300.2 million, representing a 7.4% year-over-year increase. The combination of new facility launches, strategic acquisitions, and enhanced patient workflow efficiency propelled both revenue and profitability metrics.

Management forecasts 2026 Imaging Center revenue expansion of 17%-19% with adjusted EBITDA growth of 18%-22%. Free cash flow generation is projected to accelerate 29%-41% above 2025 performance. Strategic priorities include operational efficiency enhancements, capacity optimization initiatives, and advantageous reimbursement positioning.

Digital Health Platform Accelerates Through AI Innovation

Digital Health revenue expanded 41.1% throughout 2025, reaching $92.7 million, underpinned by predictable recurring revenue models. Adjusted EBITDA improved to $15.5 million, reflecting continued investment in clinical AI capabilities and workflow automation technologies. Annual Recurring Revenue (ARR) constituted 81.3% of 2025 segment revenue, demonstrating substantial subscription resilience.

The strategic acquisition of Gleamer SAS in 2026 broadens RadNet’s Digital Health portfolio in AI-powered clinical applications. Management anticipates securing multiple FDA clearances across mammography, pulmonary, prostate, thyroid, and musculoskeletal diagnostic areas. The proportion of Digital Health revenue derived from internal Imaging Center operations is expected to decrease from 45% to 33% in 2026, signaling broader market penetration.

For fiscal 2026, Digital Health guidance establishes a revenue range of $135-$145 million, with adjusted EBITDA before non-capitalized R&D expenses projected at $10-$12 million. Free cash flow, after accounting for non-capitalized research and development expenditures, is anticipated at negative $17-$19 million. Substantial investments in infrastructure development and team expansion aim to enable scalable growth trajectories and widespread industry adoption of sophisticated AI solutions.

The post RadNet (RDNT) Delivers Record-Breaking Q4 2025 Results as Digital Health Revenue Climbs 48% appeared first on Blockonomi.

Market Opportunity
Radiant Logo
Radiant Price(RDNT)
$0.004283
$0.004283$0.004283
-0.87%
USD
Radiant (RDNT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

USDH Power Struggle Ignites Stablecoin “Bidding Wars” Across DeFi: Bloomberg

USDH Power Struggle Ignites Stablecoin “Bidding Wars” Across DeFi: Bloomberg

A heated contest for control over a new dollar-pegged token has set the stage for what analysts say could define the next phase of the stablecoin industry. According to Bloomberg, a bidding war unfolded on Hyperliquid, one of crypto’s fastest-growing trading platforms, with the prize being the right to issue USDH, its native stablecoin. The competition drew some of the sector’s most prominent names, including Paxos, Sky, and Ethena, who later withdrew their bid, alongside the lesser-known Native Markets, a startup backed by Stripe stablecoin subsidiary Bridge. Hyperliquid Stablecoin Race Shows Branding and Partnerships Matter as Much as Tech Over the weekend, Hyperliquid’s validators, the contributors who secure the network and vote on key decisions, awarded the USDH contract to Native Markets over the weekend. Despite its relatively new status, the firm’s connection with Stripe helped it outpace more established rivals. Stablecoins underpin decentralized finance by providing a dollar-backed medium for collateral, settlement, and payments across applications. What began as a grassroots, community-led sector has evolved into a battleground for institutions and payment companies seeking revenue from interest on reserves. Circle, for example, shares proceeds from its USDC with Coinbase under a partnership designed to stabilize earnings during market swings. The Hyperliquid contest offered a rare glimpse into just how intense competition has become. Paxos pledged to take no revenue until USDH surpassed $1 billion in circulation. Agora offered to share 100% of net revenue with Hyperliquid, while Ethena put forward 95%. All were outbid by Native Markets, whose ties to Stripe’s $1.1 billion acquisition of Bridge and subsequent rollout of the Tempo blockchain positioned it as a strong contender. “Every stablecoin issuer is extremely desperate for supply,” said Zaheer Ebtikar, co-founder of Split Capital. “They are willing to publicly announce how much they are willing to offer. It just shows it’s a very tough business for stablecoin issuers.” While USDC remains dominant on Hyperliquid with more than $5.6 billion in deposits, the arrival of USDH could shift flows and revenue dynamics. Paxos co-founder Bhau Kotecha said the firm sees the exchange’s growth as an important opportunity, while Agora’s co-founder Nick van Eck warned that awarding the contract to a vertically integrated issuer risked undermining decentralization. Regulatory positioning also factored into the debate. Paxos operates under a New York trust charter and is seeking a federal license, while Bridge holds money transmitter approvals in 30 states. Native Markets, in a blog post, cited regulatory flexibility and deployment speed as reasons for its selection. Hyperliquid said the strong engagement from its community validated the process. Circle CEO Jeremy Allaire dismissed concerns over USDC’s status, noting on X that competition benefits the ecosystem. Analysts suggested that fears of centralization may be exaggerated, noting that Hyperliquid is likely to remain neutral and support multiple stablecoins. Still, the contest over USDH highlighted a new reality for stablecoins: branding, partnerships, and business strategy are becoming as decisive as technology. Native Markets Secures USDH Stablecoin Mandate on Hyperliquid Hyperliquid has concluded its governance vote for the USDH stablecoin, awarding the mandate to Native Markets after a closely watched process that drew weeks of community debate and rival proposals. USDH, described by Hyperliquid as a “Hyperliquid-first, compliant, and natively minted” dollar-backed token, is intended to reduce the platform’s dependence on USDC and strengthen its spot markets. Validators on the decentralized exchange voted in favor of Native Markets, a relatively new player backed by Stripe’s Bridge subsidiary, over established contenders including Paxos and Ethena. The outcome followed a string of proposals offering aggressive revenue-sharing terms to win validator support, underscoring the scale of incentives attached to controlling USDH. Hyperliquid’s exchange has become a critical hub for stablecoin liquidity, with $5.7 billion in USDC, around 8% of its total supply, currently held on the network. At prevailing treasury yields, that translates to an estimated $200 million to $220 million in annual revenue for Circle, underlining why a native alternative could be transformative. Hyperliquid’s validators, who secure the network and vote on key decisions, selected Native Markets following an on-chain governance process that concluded September 15. Native Markets has laid out a phased rollout for USDH, beginning with capped minting and redemption trials before expanding into spot markets. Its reserves will be managed in cash and treasuries by BlackRock, with on-chain tokenization through Superstate and Bridge. Yield from those reserves will be split between Hyperliquid’s Assistance Fund and ecosystem development. The launch of USDH comes as Hyperliquid records record profits from perpetual futures trading, with $106 million in revenue in August alone, and prepares to slash spot trading fees by 80% to bolster liquidity. Analysts say the move positions Hyperliquid to capture more of the stablecoin economics internally, marking a significant step in its bid to rival the largest players in decentralized finance
Share
CryptoNews2025/09/18 00:48
Bitcoin Market Faces Renewed Pressure: What Lies Ahead?

Bitcoin Market Faces Renewed Pressure: What Lies Ahead?

The post Bitcoin Market Faces Renewed Pressure: What Lies Ahead? appeared on BitcoinEthereumNews.com. Recent data reveals heightened instability in the cryptocurrency
Share
BitcoinEthereumNews2026/03/31 01:21
BTC fell below $67,000, down 0.94% on the day.

BTC fell below $67,000, down 0.94% on the day.

PANews reported on March 31 that, according to OKX market data, BTC has just fallen below $67,000 and is currently trading at $66,989.20 per coin, down 0.94% on
Share
PANews2026/03/31 01:22